1. Home
  2. VICR vs GRFS Comparison

VICR vs GRFS Comparison

Compare VICR & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vicor Corporation

VICR

Vicor Corporation

HOLD

Current Price

$170.01

Market Cap

7.6B

Sector

Technology

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$9.40

Market Cap

6.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VICR
GRFS
Founded
1981
1940
Country
United States
Spain
Employees
1100
23800
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.6B
6.5B
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
VICR
GRFS
Price
$170.01
$9.40
Analyst Decision
Strong Buy
Hold
Analyst Count
3
2
Target Price
$132.50
$10.15
AVG Volume (30 Days)
538.7K
433.1K
Earning Date
05-24-2026
01-01-0001
Dividend Yield
N/A
1.51%
EPS Growth
N/A
N/A
EPS
1.59
N/A
Revenue
N/A
N/A
Revenue This Year
$28.74
$5.47
Revenue Next Year
$3.49
$4.92
P/E Ratio
$106.92
$18.67
Revenue Growth
N/A
N/A
52 Week Low
$38.93
$6.19
52 Week High
$177.00
$11.14

Technical Indicators

Market Signals
Indicator
VICR
GRFS
Relative Strength Index (RSI) 53.45 51.85
Support Level $151.52 $9.33
Resistance Level $163.73 $9.77
Average True Range (ATR) 13.05 0.23
MACD -2.43 0.01
Stochastic Oscillator 58.82 44.28

Price Performance

Historical Comparison
VICR
GRFS

About VICR Vicor Corporation

Vicor Corp manufactures and markets modular power components and complete power systems for converting electrical power. It provides modular power converters and configurable products, power component products and integrated circuits, and related products. Its products include Converters, Power Systems, Filters, Custom Power Systems, Input Modules, and others.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: